(Q48018300)

7 February 2018

review article

1 reference

title

Percent free prostate-specific antigen: the next frontier in prostate-specific antigen testing (English)

1 reference

7 February 2018

author name string

Beduschi MC

series ordinal

1

1 reference

7 February 2018

Oesterling JE

series ordinal

2

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 May 1998

1 reference

7 February 2018

published in

Urology

1 reference

7 February 2018

volume

51

1 reference

7 February 2018

issue

5A Suppl

1 reference

7 February 2018

page(s)

98-109

1 reference

7 February 2018

cites work

Cancer statistics, 1996.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Isolation and Characterization of Two Specific Antigens of Human Seminal Plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

The Clinical Usefulness of Prostate Specific Antigen: Update 1994

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

The Nature of Prostate Cancer Detected Through Prostate Specific Antigen Based Screening

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Clinical Stage B0 or T1c prostate cancer: nonpalpable disease identified by elevated serum prostate-specific antigen concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Sustained, substantially increased concentration of prostate-specific antigen in the absence of prostatic malignant disease: an unusual clinical scenario

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Clinical behavior of prostatic specific antigen and prostatic acid phosphatase: a comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Human prostate-specific antigen: structural and functional similarity with serine proteases

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Molecular cloning of human prostate specific antigen cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Isolation, characterization and amino-acid sequence of gamma-seminoprotein, a glycoprotein from human seminal plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

The chymotrypsin-like activity of human prostate-specific antigen, gamma-seminoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Characterization of the human kallikrein locus

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Immunoreactive prostate-specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Extraprostatic localization of prostatic acid phosphatase and prostate-specific antigen: distribution in cloacogenic glandular epithelium and sex-dependent expression in human anal gland

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Primary structure of a human glandular kallikrein gene

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Production of recombinant PSA and HK2 and analysis of their immunologic cross-reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Molecular forms of serum prostate-specific antigen. The clinical value of percent free prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Detection of a prostate-specific protein, human glandular kallikrein (hK2), in sera of patients with elevated prostate-specific antigen levels

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Complex formation between protein C inhibitor and prostate-specific antigen in vitro and in human semen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Longitudinal analysis of serial measurements of free and total PSA among men with and without prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Comparability of the tandem-R andIMx assays for the measurement of serum prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Production of alpha-1-antichymotrypsin by PSA-containing cells of human prostate epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Alpha 1-antichymotrypsin production in PSA-producing cells is common in prostate cancer but rare in benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

The value of screening tests in the detection of prostate cancer. Part I: Results of a retrospective evaluation of 1726 men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Determination of the "reflex range" and appropriate cutpoints for percent free prostate-specific antigen in 413 men referred for prostatic evaluation using the AxSYM system

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Using proportions of free to total prostate-specific antigen, age, and total prostate-specific antigen to predict the probability of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Prostate-specific antigen density

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2990059-0

7 January 2021

10.1016/S0090-4295(98)90059-0

Identifiers

DOI

1 reference

7 February 2018

1 reference

7 February 2018